Introduction:

Biktarvy and Genvoya are two medications used to treat HIV. They are combination therapies, meaning they contain multiple medicines in one pill. Let’s look at how they compare.

Mechanism of Action:

•             How Biktarvy works: Biktarvy contains three medicines that help stop HIV from making copies of itself. It is taken once a day.

•             How Genvoya works: Genvoya is similar, but it contains slightly different medicines. It’s also taken once a day.

Efficacy:

•             Viral suppression: Both Biktarvy and Genvoya are very effective at keeping HIV levels low in the blood. Clinical trials show that they both work well for most people.

•             Safety profiles: Biktarvy might be safer for people with kidney problems, while Genvoya may have more impact on kidney function.

Side Effects:

•             Biktarvy: Common side effects include nausea and headache. It’s generally safe for long-term use.

•             Genvoya: Genvoya has similar side effects, but it can affect kidney function over time, so monitoring is important.

Cost and Accessibility:

•             Pricing: Both Biktarvy and Genvoya are expensive, but insurance often covers them.

•             Patient assistance programs: Both medications have patient assistance programs to help reduce costs. Resources like HIV clinics can also be very helpful for additional support.

Conclusion:

Both Biktarvy and Genvoya are effective for treating HIV, but Biktarvy might be better for people with kidney issues. Your doctor can help you decide which is the best option for your health.